NASDAQ:ACRS
Aclaris Therapeutics Stock Signals
Latest Data & Signals Issued
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -3.197 | 41 days ( 43.55 % ) | |
| Last Price | $8.09 | -2.88 % | |
| High/ Low | $8.04 - $8.73 | 13.31% | |
| Chg 7 Days | 1.00 % | $8.01 $8.09 | |
| Chg 30 Days | -33.91 % | $12.24 $8.09 | |
| Chg 12 mos | -53.07 % | $17.24 $8.09 | |
| Trend - 3 mos | -55.06 % | Width: 164.50 % | |
| Trend - 12 mos | -11.10 % | Width: 154.66 % | |
| Pred. range - 3 mos | $1.58 - $4.18 | -80.46 % - -48.31 % | |
| Pred. range - 12 mos | $6.14 - $15.63 | -24.14 % - 93.19 % | |
| Short mv avg 3 mos | Sell | 2023-03-30 - 2 days | |
| Long mv avg 3 mos | Sell | 2023-02-01 - 42 days | |
| Short/Long mv avg 3 mos | Sell | 2023-02-03 - 40 days | |
| Short mv avg 12 mos | Sell | 2023-03-30 - 2 days | |
| Long mv avg 12 mos | Sell | 2023-02-01 - 42 days | |
| Short/Long mv avg 12 mos | Sell | 2023-02-07 - 38 days | |
| Pivot Short | Buy | 2023-03-06 - 20 days | |
| Bollinger | Buy | 2023-02-03 - 40 days | |
| MACD | Buy | No Dates Stored For This Signal |
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
